Adaptive Neuro-Fuzzy Modeling of Poorly Soluble Drug Formulations

PurposeThe purpose of this study was to evaluate the efficiency of a neuro-fuzzy logic-based methodology to model poorly soluble drug formulations and predict the development of the particle size that has been proven to be an important factor for long-term stability.MethodsAn adaptive neuro-fuzzy inference system was used to model the natural structures within the data and construct a set of fuzzy rules that can subsequently used as a predictive tool. The model was implemented in Matlab 6.5 and trained using 75% of an experimental data set. Subsequently, the model was evaluated and tested using the remaining 25%, and the predicted values of the particle size were compared to the ones from the experimental data. The produced adaptive neuro-fuzzy inference system-based model consisted of four inputs, i.e., acetone, propylene glycol, POE-5 phytosterol (BPS-5), and hydroxypropylmethylcellulose 90SH-50, with four membership functions each. Moreover, 256 fuzzy rules were employed in the model structure.ResultsModel training resulted in a root mean square error of 4.5 × 10−3, whereas model testing proved its highly predictive efficiency, achieving a correlation coefficient of 0.99 between the actual and the predicted values of the particle size (mean diameter).ConclusionsNeuro-fuzzy modeling has been proven to be a realistic and promising tool for predicting the particle size of drug formulations with an easy and fast way, after proper training and testing.

[1]  Kozo Takayama,et al.  Artificial Neural Network as a Novel Method to Optimize Pharmaceutical Formulations , 2004, Pharmaceutical Research.

[2]  I Horikoshi,et al.  Optimization of the formulation design of chitosan microspheres containing cisplatin. , 1996, Journal of pharmaceutical sciences.

[3]  T. Ross.  Fuzzy Logic with Engineering Applications , 1994 .

[4]  Hans Leuenberger,et al.  Albumin Nanospheres as Carriers for Passive Drug Targeting: An Optimized Manufacturing Technique , 2004, Pharmaceutical Research.

[5]  J. Crison,et al.  A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability , 1995, Pharmaceutical Research.

[6]  Masayuki Matsui,et al.  An application of the computer optimization technique to wet granulation process involving explosive growth of particles , 1997 .

[7]  R. Filmon,et al.  Optimization of HSA and NGF encapsulation yields in PLGA microparticles , 1998 .

[8]  N. Rasenack,et al.  Dissolution Rate Enhancement by in Situ Micronization of Poorly Water-Soluble Drugs , 2002, Pharmaceutical Research.

[9]  N. Rasenack,et al.  Micronization of anti-inflammatory drugs for pulmonary delivery by a controlled crystallization process. , 2003, Journal of pharmaceutical sciences.

[10]  Andreas Kroll,et al.  Identification of functional fuzzy models using multidimensional reference fuzzy sets , 1996, Fuzzy Sets Syst..

[11]  R. Herrero-Vanrell,et al.  Optimisation of aciclovir poly(D,L-lactide-co-glycolide) microspheres for intravitreal administration using a factorial design study. , 2004, International journal of pharmaceutics.

[12]  L. Augsburger,et al.  Applying the biopharmaceutics classification system to veterinary pharmaceutical products. Part I: biopharmaceutics and formulation considerations. , 2002, Advanced drug delivery reviews.

[13]  Christopher T. Rhodes,et al.  Artificial Neural Networks: Implications for Pharmaceutical Sciences , 1995 .

[14]  R. H. Myers,et al.  Response Surface Methodology: Process and Product Optimization Using Designed Experiments , 1995 .

[15]  J. Hadgraft,et al.  Formation and stabilisation of triclosan colloidal suspensions using supersaturated systems. , 2003, International journal of pharmaceutics.

[16]  A. Noyes,et al.  The rate of solution of solid substances in their own solutions , 1897 .

[17]  G. Derringer,et al.  Simultaneous Optimization of Several Response Variables , 1980 .

[18]  Boriana L. Milenova,et al.  Fuzzy and neural approaches in engineering , 1997 .

[19]  Mohammad Bagher Menhaj,et al.  Training feedforward networks with the Marquardt algorithm , 1994, IEEE Trans. Neural Networks.

[20]  Gregorios G Agyralides,et al.  Development and in vitro evaluation of furosemide transdermal formulations using experimental design techniques. , 1995, International journal of pharmaceutics.

[21]  Kozo Takayama,et al.  Neural network based optimization of drug formulations. , 2003, Advanced drug delivery reviews.

[22]  Andreas Kroll,et al.  Nonlinear Black Box Modelling – Fuzzy Networks versus Neural Networks , 1999, Neural Computing & Applications.

[23]  A. Khuri,et al.  Simultaneous Optimization of Multiple Responses Represented by Polynomial Regression Functions , 1981 .

[24]  C T Hung,et al.  Optimized synthesis of polyglutaraldehyde nanoparticles using central composite design. , 1988, Journal of pharmaceutical sciences.

[25]  Padhraic Smyth,et al.  From Data Mining to Knowledge Discovery: An Overview , 1996, Advances in Knowledge Discovery and Data Mining.

[26]  Lotfi A. Zadeh,et al.  Fuzzy Sets , 1996, Inf. Control..

[27]  Gordon L. Amidon,et al.  Mixture Experimental Design in the Development of a Mucoadhesive Gel Formulation , 1991, Pharmaceutical Research.

[28]  G. Mie.  Beiträge zur Optik trüber Medien, speziell kolloidaler Metallösungen , 1908 .

[29]  W. Hennink,et al.  The effect of formulation parameters on the size of poly-((2-dimethylamino)ethyl methacrylate)-plasmid complexes. , 1999, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[30]  Jyh-Shing Roger Jang,et al.  ANFIS: adaptive-network-based fuzzy inference system , 1993, IEEE Trans. Syst. Man Cybern..

[31]  R. Löbenberg,et al.  Modern bioavailability, bioequivalence and biopharmaceutics classification system. New scientific approaches to international regulatory standards , 2000 .

[32]  Yixin Chen,et al.  Application of artificial neural networks in the design of controlled release drug delivery systems. , 2003, Advanced drug delivery reviews.

[33]  Angela K. Pannier,et al.  Fuzzy Modeling of Skin Permeability Coefficients , 2004, Pharmaceutical Research.